Low-Dose IL-2 Boosts Tregs in Lupus Patients
In a groundbreaking development that promises to reshape therapeutic approaches for autoimmune diseases, a recent phase IIb clinical trial has ...
In a groundbreaking development that promises to reshape therapeutic approaches for autoimmune diseases, a recent phase IIb clinical trial has ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine